Work

Supplementary Figure 4 from Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 4: The change in PBMCs for patients with clinical benefit (blue) and no benefit (red).

DOI: 10.1158/2767-9764.23593091.v1

Authors: Michael Cecchini, Janie Y. Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M. Stein, Jeremy Kortmansky, Kimberly L. Johung, Ranjit S. Bindra, Patricia LoRusso, Kurt A. Schalper

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4382395783

Cites:

Cited by:

Related to: 10